SCHEMBL30406904

SCHEMBL30406904

FC1(F)CC(Nc2ncc3c(-c4ccc5ncccc5c4)c[nH]c3n2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 5/20 0.53
▸ CLK2 P49760 2/20 0.53
▸ CLK3 P49761 2/20 0.53
▸ CLK1 P49759 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ DYRK1B Q9Y463 3/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CCNK O75909 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ CDK12 Q9NYV4 1/20 0.38
▸ RET P07949 2/20 0.37
▸ EIF2AK4 Q9P2K8 2/20 0.37
▸ CDC7 O00311 4/20 0.37
▸ TLR8 Q9NR97 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25157418 1.00 DYRK1A (0.53) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL30346470 0.90 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25157796 0.90 DYRK1A (0.51) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL30348643 0.89 DYRK1A (0.41) DYRK1ACLK2CLK3DYRK1BBRD4
SCHEMBL25519911 0.89 DYRK1A (0.41) DYRK1ACLK2CLK3DYRK1BBRD4
SCHEMBL25157431 0.86 TDO2 (0.49) DYRK1ACLK2CLK3BRD4CCNT1
SCHEMBL30347199 0.86 TDO2 (0.49) DYRK1ACLK2CLK3BRD4CCNT1
SCHEMBL25157324 0.86 DYRK1A (0.54) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25158041 0.84 DYRK1A (0.55) DYRK1ACLK2CLK3CLK1CLK4
SCHEMBL25157421 0.84 DYRK1A (0.53) DYRK1ACLK2CLK3CLK1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback